Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Analysis of Response Markers and Adverse Events in a Nationwide Cohort of Advanced Melanoma Patients Treated With Pembrolizumab

NCT02600169 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT02600169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02600169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Analysis of Response Markers and Adverse Events in a Nationwide Cohort of Advanced Melanoma Patients Treated With Pembrolizumab
Lead sponsor
University Medical Center Groningen
Phase
Observational
Overall status
Completed
Start date
July 31, 2015
Completion date
April 30, 2019
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma